跳至主要内容
临床试验/NCT00955123
NCT00955123已完成不适用

Effects of Prednisolone and Infliximab on the Regulation of Urea Synthesis in Patients With Active Ulcerative Colitis and Crohn's Disease

University of Aarhus1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Functional Hepatic Nitrogen Clearance

研究概览

简要总结

Loss of total mass of muscles (catabolism) is a serious clinical problem in patients with active inflammatory bowel disease (IBD). The investigators have earlier shown that the liver plays an important role in this stress-catabolism by increasing the production of urea during the inflammatory process.

The purpose of this study is to examine the effect of the anti-inflammatory drugs prednisolone and infliximab on the regulation of the urea synthesis in patients with active ulcerative colitis and Crohn's disease.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate to severe active inflammatory bowel disease

排除标准

  • Viral or bacterial infections
  • Other chronical inflammatory diseases
  • Other catabolic diseases
  • Treatment with prednisolone or infliximab within the last 8 weeks

结局指标

主要结局

Functional Hepatic Nitrogen Clearance

时间窗: Before and one week after treatment

次要结局

  • Clinical and biochemical measures of inflammation(Before and one week after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karen Louise Thomsen

Dr.

University of Aarhus

研究点 (1)

Loading locations...

相似试验